Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is human hibernation possible?

Cheng Chi Lee1

  • 1Department of Biochemistry and Molecular Biology, University of Texas Health Science Center, Houston, Texas 77030, USA. cheng.c.lee@uth.tmc.edu

Annual Review of Medicine
|January 12, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rathke's cleft cyst classification and outcomes after endoscopic endonasal approach.

Clinical neurology and neurosurgery·2023
Same author

Circadian period 2: a missing beneficial factor in sickle cell disease by lowering pulmonary inflammation, iron overload, and mortality.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2019
Same author

New insights on the regulation of the adenine nucleotide pool of erythrocytes in mouse models.

PloS one·2017
Same author

Interactive Organization of the Circadian Core Regulators PER2, BMAL1, CLOCK and PML.

Scientific reports·2016
Same author

The Small Molecule Nobiletin Targets the Molecular Oscillator to Enhance Circadian Rhythms and Protect against Metabolic Syndrome.

Cell metabolism·2016
Same author

5'-adenosine monophosphate mediated cooling treatment enhances ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) stability in vivo.

Journal of biomedical science·2015
Same journal

Dupilumab Emerges as an Effective Antibody Therapy for Eosinophilic Esophagitis.

Annual review of medicine·2026
Same journal

CAR T Cell Toxicities and Emerging Treatment Strategies.

Annual review of medicine·2026
Same journal

Transthyretin Amyloid Cardiomyopathy: A Rapidly Evolving Landscape.

Annual review of medicine·2026
Same journal

Accessibility of Somatic Genetic Testing for Cancer Treatment Decisions.

Annual review of medicine·2026
Same journal

Diffuse Parenchymal Lung Disease: Updates in Pathophysiology and Management.

Annual review of medicine·2026
Same journal

Revascularization for Ischemic Cardiomyopathy: Disproving the 45-Year-Old Concept of Hibernating Myocardium.

Annual review of medicine·2026
See all related articles

Scientists discovered a biomolecule, 5'-AMP, enabling safe, severe hypothermia in mammals. This breakthrough could revolutionize treatments for stroke and heart attack by reducing ischemia damage.

Area of Science:

  • Biochemistry
  • Physiology
  • Medical Science

Background:

  • Hypometabolism and hypothermia offer clinical benefits by reducing cellular metabolic demands, particularly for ischemia damage.
  • Hibernation in mammals demonstrates safe, severe hypothermia with full viability restoration, but the mechanism remains unknown.
  • Current clinical methods for inducing severe hypothermia in nonhibernators are difficult and carry high risks, including cardiac arrest.

Purpose of the Study:

  • To explore the potential of inducing severe hypothermia in nonhibernating mammals.
  • To identify biomolecules that could facilitate safe and rapid entry into hypothermic states.
  • To overcome the limitations of current clinical hypothermia induction methods.

Main Methods:

  • Investigated the effects of specific biomolecules on metabolic states in nonhibernating mammals.

Related Experiment Videos

  • Assessed the safety and efficacy of induced hypothermia.
  • Analyzed the potential of 5 eal-AMP (adenosine monophosphate) in facilitating hypothermia.

    • Main Results:

    • The biomolecule 5 eal-AMP was identified as capable of inducing rapid and safe severe hypothermia in nonhibernating mammals.
    • This discovery suggests a potential mechanism for controlled hypothermia induction, bypassing risks associated with current methods.
    • The findings pave the way for further research into hibernation-like states.

    Conclusions:

    • 5 eal-AMP represents a significant advancement, potentially enabling the widespread clinical application of hypothermia.
    • This biomolecule could mitigate ischemia damage in conditions like stroke and heart attack.
    • Further research is warranted to fully elucidate the mechanisms and clinical applications of 5 eal-AMP-induced hypothermia.